New prescribing approach could reduce intravenous opioid exposure
Intravenous opioid doses were reduced by 84% and pain scores improved after researchers trialled a new prescribing standard that favours oral and subcutaneous administration.
A new standard of inpatient opioid prescribing preferring oral and subcutaneous administration may be associated with significant reductions in intravenous opioid exposure, results from a US study show.
Researchers compared opioid use from the beginning of a six-month control period to three months after adoption of the new standard, which was initiated alongside education for prescribers and nursing staff on awareness of the subcutaneous route.
They found that intravenous opioid doses were reduced by 84% during the intervention period and combined doses of parenteral opioids, given either intravenously or subcutaneously, were reduced by 55%.
The daily rate of patients administered any parenteral opioid decreased by 57% during the intervention period. The researchers also found that pain scores improved significantly in the intervention group on days four and five after intervention.
Lead author, Adam Ackerman, said: “Intravenous opioids commonly given in hospitals for pain control are an especially dangerous source of exposure.
“Our study suggests that ensuring providers and nurses are made aware of less risky methods of giving opioids can lead to less overall exposure for patients while still controlling their pain.”
Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205055
Recommended from Pharmaceutical Press
A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.£54.00
Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.£138.50
Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.£262.50
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00